Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1997-10-15
|
| pubmed:abstractText |
Quality of life measurements gained increasing importance in the last years. After lung tissue reducing interventions for bronchogenic carcinoma quality of life measurements play an important role, since quality of life can be decisively influenced by post-operative reduced lung function. On the basis of postoperative physical symptoms and lung function the restriction of quality of life after pneumonectomy should be analyzed with respect to intervention and adjuvant therapy, 36 patients with an average age of 61 years were followed up by ambulatory oncological care for 40 months (median) after operation and lung function as well as quality of life were measured by self assessment index QLQ- C 30 of EORTC. RESULTS: Beside physical symptoms (increasing of dyspnea by 61.1% and pain by 30.6% after pneumonectomy as compared to preoperative values) the significant reduced lung function (IVC by 33.5%, FEV 1 by 27.1%) and the QL-measurement showed the greatest restrictions, latter in "Physical functioning" by 27.2%, in "Role functioning" by 45.8% and in "Global health status/ Quality of life" by 45.6%. The symptoms "Fatigue" (Score 39.8), "Dyspnea" (50,9), "Pain" (29.6) and "Sleep disturbance" (35.2; max. score 100 = high frequency) were most often found. Further adjuvant therapy (at least 6 months after completion) in 11 patients and the type of pneumonectomy (right-side: n = 11, left-side: n = 25) did not result in additional significant reduction of lung function and of single quality of life dimensions, except that "Dyspnea" in patients with right-sided pneumonectomy (66.7) was significantly more frequent than in patients with left-sided pneumonectomy (44.0). CONCLUSIONS: In this study the restricted quality of life after pneumonectomy was mainly caused by reduction of cardiopulmonary function (reduced lung function by loss of parenchyma). Adjuvant therapy reduced neither lung function nor quality of life. Compared to quality of life measurements after lung resection [17] quality of life after pneumonectomy didn't worse.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0044-409X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
122
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
327-31
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9334092-Activities of Daily Living,
pubmed-meshheading:9334092-Adenocarcinoma,
pubmed-meshheading:9334092-Adult,
pubmed-meshheading:9334092-Aged,
pubmed-meshheading:9334092-Carcinoma, Bronchogenic,
pubmed-meshheading:9334092-Carcinoma, Small Cell,
pubmed-meshheading:9334092-Carcinoma, Squamous Cell,
pubmed-meshheading:9334092-Female,
pubmed-meshheading:9334092-Follow-Up Studies,
pubmed-meshheading:9334092-Forced Expiratory Volume,
pubmed-meshheading:9334092-Humans,
pubmed-meshheading:9334092-Lung Neoplasms,
pubmed-meshheading:9334092-Male,
pubmed-meshheading:9334092-Middle Aged,
pubmed-meshheading:9334092-Neoplasm Staging,
pubmed-meshheading:9334092-Pneumonectomy,
pubmed-meshheading:9334092-Postoperative Complications,
pubmed-meshheading:9334092-Quality of Life,
pubmed-meshheading:9334092-Treatment Outcome,
pubmed-meshheading:9334092-Vital Capacity
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
[Quality of life after pneumonectomy for bronchial carcinoma].
|
| pubmed:affiliation |
Klinik für Innere Medizin II, Martin-Luther-Universität Halle-Wittenberg.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|